Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.22 (
cdc2
)
8,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Geminin is an unstable inhibitor of DNA replication that negatively regulates the licensing factor
CDT1
and inhibits pre-replicative complex (pre-RC) formation in Xenopus egg extracts. Here we describe a novel function of Geminin. We demonstrate that human Geminin protects
CDT1
from proteasome-mediated degradation by inhibiting its ubiquitination. In particular, Geminin ensures basal levels of
CDT1
during S phase and its accumulation during mitosis. Consistently, inhibition of Geminin synthesis during M phase leads to impairment of pre-RC formation and DNA replication during the following cell cycle. Moreover, we show that inhibition of CDK1 during mitosis, and not Geminin depletion, is sufficient for premature formation of pre-RCs, indicating that
CDK
activity is the major mitotic inhibitor of licensing in human cells. Taken together with recent data from our laboratory, our results demonstrate that Geminin is both a negative and positive regulator of pre-RC formation in human cells, playing a positive role in allowing
CDT1
accumulation in G2-M, and preventing relicensing of origins in S-G2.
...
PMID:Human geminin promotes pre-RC formation and DNA replication by stabilizing CDT1 in mitosis. 1525 90
In eukaryotic cells, the function of DNA replication licensing components (Cdc6 and Cdt1, among others) is crucial for cell proliferation and genome stability. However, little is known about their role in whole organisms and whether licensing control interfaces with differentiation and developmental programs. Here, we study Arabidopsis thaliana
CDT1
, its regulation, and the consequences of overriding licensing control. The availability of AtCDT1 is strictly regulated at two levels: (1) at the transcription level, by E2F and growth-arresting signals, and (2) posttranscriptionally, by
CDK
phosphorylation, a step that is required for its proteasome-mediated degradation. We also show that CDC6 and
CDT1
are key targets for the coordination of cell proliferation, differentiation, and development. Indeed, altered
CDT1
or CDC6 levels have cell type-specific effects in developing Arabidopsis plants: in leaf cells competent to divide, cell proliferation is stimulated, whereas in cells programmed to undergo differentiation-associated endoreplication rounds, extra endocycles are triggered. Thus, we propose that DNA replication licensing control is critical for the proper maintenance of proliferative potential, developmental programs, and morphogenetic patterns.
...
PMID:DNA replication licensing affects cell proliferation or endoreplication in a cell type-specific manner. 1531 10
E-type cyclins are thought to drive cell-cycle progression by activating cyclin-dependent kinases, primarily CDK2. We previously found that cyclin E-null cells failed to incorporate MCM helicase into DNA prereplication complex during G(0) --> S phase progression. We now report that a kinase-deficient cyclin E mutant can partially restore MCM loading and S phase entry in cyclin E-null cells. We found that cyclin E is loaded onto chromatin during G(0) --> S progression. In the absence of cyclin E,
CDT1
is normally loaded onto chromatin, whereas MCM is not, indicating that cyclin E acts between
CDT1
and MCM loading. We observed a physical association of cyclin E with
CDT1
and with MCMs. We propose that cyclin E facilitates MCM loading in a kinase-independent fashion, through physical interaction with
CDT1
and MCM. Our work indicates that-in addition to their function as
CDK
activators-E cyclins play kinase-independent functions in cell-cycle progression.
...
PMID:Kinase-independent function of cyclin E. 1724 24